Dr. Hina Khan, a board-certified hematologist-oncologist, was featured in MDLinx discussing why some lung cancers stop responding to treatment over time. She explains how changes in the cancer can make therapies less effective and highlights newer treatment options, including targeted and combination therapies, that are helping doctors better manage resistant disease and improve patient care.